fingolimod hydrochloride has been researched along with Dry Eye Syndromes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, R; Fu, S; Sun, F; Xiao, W; Xu, K; Ye, W | 1 |
| Xiao, W; Xu, GT; Ye, W; Zhang, J; Zhang, Y | 1 |
| Sun, L; Xiao, W; Ye, W; Zhang, N | 1 |
3 other study(ies) available for fingolimod hydrochloride and Dry Eye Syndromes
| Article | Year |
|---|---|
Fingolimod Suppresses a Cascade of Core Vicious Cycle in Dry Eye NOD Mouse Model: Involvement of Sphingosine-1-Phosphate Receptors in Infiltrating Leukocytes.
Topics: Animals; Blotting, Western; Disease Models, Animal; Dry Eye Syndromes; Fingolimod Hydrochloride; Immunohistochemistry; Immunosuppressive Agents; Leukocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Receptors, Lysosphingolipid; Sphingosine | 2017 |
FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
Topics: Animals; Cell Count; Conjunctiva; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Goblet Cells; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lacrimal Apparatus; Leukocytes; Male; Mice; Mice, Inbred NOD; Real-Time Polymerase Chain Reaction; Regeneration; RNA, Messenger; Tears; Tumor Necrosis Factor-alpha | 2015 |
Adverse Effect Profile of Topical Ocular Administration of Fingolimod for Treatment of Dry Eye Disease.
Topics: Animals; Cornea; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Fingolimod Hydrochloride; Leukocytes; Mice, Inbred BALB C; Ophthalmic Solutions; Retina | 2017 |